Clinical Trials Browser

Interventional × Recurrence × rilotumumab × Clear all

NCT01233687 2017-06-22

AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer

Phase 1/2 Completed

49 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT01113398 2015-12-10

AMG 102 and Avastin for Recurrent Malignant Glioma

Phase 2 Completed

36 enrolled 9 charts

Glioblastoma, Glioma, Recurrence, Gliosarcoma